IAI CONFERENCE: Fluconazole-tartaric acid co-crystal formation and its mechanical properties
DOI:
https://doi.org/10.46542/pe.2021.212.116122Keywords:
Flowability, Fluconazole, Tartaric acid, Mechanical properties, Ultrasound-assisted solution co-crystallisation (USSC), TabletabilityAbstract
Introduction: The formation of co-crystal is widely studied to obtain more favourable physicochemical properties than the pure active pharmaceutical ingredient (API). The co-crystal formation between an anti-fungal drug, fluconazole (FLU), and tartaric acid (TAR) has been investigated and its impact on mechanical properties has also been studied.
Methods: The co-crystal of FLU-TAR (1:1) molar ratio was prepared by ultrasound-assisted solution co-crystallization (USSC) method with ethanol as the solvent. Polarization microscopy was used to observe the crystal morphology. Meanwhile, powder X-ray diffraction (PXRD) and differential scanning calorimetry (DSC) methods were used to characterise the co-crystal formation. The mechanical properties of the co-crystal, such as flowability and tablet-ability, were compared with pure FLU.
Results: Photomicroscopes revealed the unique crystal morphology of the USSC product was different from the two starting components. The typical PXRD pattern was shown by the USSC product, which indicated the formation of FLU-TAR co-crystal. In addition, the DSC thermogram revealed 169.2°C as the melting point of the FLU-TAR co-crystal, which is between the melting points of FLU and TAR. It indicates that FLU-TAR co-crystal has better flowability and tablet-ability than pure FLU.
Conclusion: FLU-TAR co-crystal is one of the alternative solid forms for a raw material in pharmaceutical tablet preparation because it has better mechanical properties than pure fluconazole.
References
Aher, S., Dhumal, R., Mahadik, K., Paradkar, A., & York, P. (2010). Ultrasound-assisted cocrystallization from solution (USSC) containing a non-congruently soluble co-crystal component pair: Caffeine/maleic acid. European Journal of Pharmaceutical Sciences, 41(5), 597–602. https://doi.org/10.1016/j.ejps.2010.08.012
Ahmed, H., Shimpi, M. R., & Velaga, S. P. (2016). Relationship between mechanical properties and crystal structure in co-crystals and salt of paracetamol. Drug Development and Industrial Pharmacy, 9045(August), 1–9. https://doi.org/10.1080/03639045.2016.1220568
Alkhamis, K. a, Obaidat, A. a, & Nuseirat, A. F. (2002). Solid-state characterization of fluconazole. Pharmaceutical Development and Technology, 7(4), 491–503. https://doi.org/10.1081/PDT-120015052
Batisai, E., Ayamine, A., Kilinkissa, O. E. Y., & Báthori, N. B. (2014). Melting point-solubility-structure correlations in multicomponent crystals containing fumaric or adipic acid. CrystEngComm, 16(43), 9992–9998. https://doi.org/10.1039/c4ce01298d
Charoo, N., Cristofoletti, R., Graham, A., Lartey, P., Abrahamsson, B., Groot, D. W., … Dressman, J. (2014). Biowaiver monograph for immediate-release solid oral dosage forms: Fluconazole. Journal of Pharmaceutical Sciences, 103(12), 3843–3858. https://doi.org/10.1002/jps.24181
Chattoraj, S., Shi, L., Chen, M., Alhalaweh, A., Velaga, S., & Sun, C. C. (2014). Origin of Deteriorated Crystal Plasticity and Compaction Properties of a 1:1 Co-crystal between Piroxicam and Saccharin. Crystal Growth & Design, 14(8), 3864–3874. https://doi.org/10.1021/cg500388s
Consiglieri, V.O., Mourão, S., Sampaio, M., Granizo, P., Garcia, P., Martinello, V., Spricigo, R., & Ferraz, H.G. (2010). Improvement of fluconazole flowability and its effect on dissolution from tablets and capsules. Brazilian Journal of Pharmaceutical Sciences, 46(1), 115–120. https://doi.org/10.1590/S1984-82502010000100013
Dayo Owoyemi, B.C., Da Silva, C.C.P., Souza, M.S., Diniz, L.F., Ellena, J., & Carneiro, R.L. (2019). Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms. Crystal Growth and Design, 19(2), 648–657. https://doi.org/10.1021/acs.cgd.8b01194
Guadalupe Sánchez-González, E., Yépez-Mulia, L., Jesús Hernández-Abad, V., & Jung Cook, H. (2015). The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules. Pharmaceutical Development and Technology, 20(3), 306–313. https://doi.org/10.3109/10837450.2013.862263
Hiendrawan, S., Veriansyah, B., Widjojokusumo, E., Soewandhi, S.N., Wikarsa, S., & Tjandrawinata, R.R. (2016). Physicochemical and mechanical properties of paracetamol co-crystal with 5-nitroisophthalic acid. International Journal of Pharmaceutics, 497(1–2), 106–113. https://doi.org/10.1016/j.ijpharm.2015.12.001
Jain, H., Khomane, K. S., & Bansal, A. K. (2014). Implication of microstructure on the mechanical behaviour of an aspirin-paracetamol eutectic mixture. CrystEngComm, 16(36), 8471–8478. https://doi.org/10.1039/c4ce00878b
Joshi, T.V., Singaraju, A.B., Shah, H.S., Morris, K.R., Stevens, L.L., & Haware, R.V. (2018). Structure-Mechanics and Compressibility Profile Study of Flufenamic Acid:Nicotinamide Cocrystal. Crystal Growth and Design, 18(10), 5853–5865. https://doi.org/10.1021/acs.cgd.8b00534
Kaialy, W., Larhrib, H., Chikwanha, B., Shojaee, S., & Nokhodchi, A. (2014). An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression. International Journal of Pharmaceutics, 464(1–2), 53–64. https://doi.org/10.1016/j.ijpharm.2014.01.026
Kaialy, W., Larhrib, H., Ticehurst, M., & Nokhodchi, A. (2012a). Influence of batch cooling crystallization on mannitol physical properties and drug dispersion from dry powder inhalers. Crystal Growth and Design, 12(6), 3006–3017. https://doi.org/10.1021/cg300224w
Kaialy, W., Larhrib, H., Ticehurst, M., & Nokhodchi, A. (2012b). Influence of Batch Cooling Crystallization on Mannitol Physical Properties and Drug Dispersion from Dry Powder Inhalers. Crystal Growth and Design, 12(6), 3006–3017. https://doi.org/10.1021/cg300224w
Karki, S., Friščić, T., Fabián, L., Laity, P.R., Day, G.M., & Jones, W. (2009). Improving mechanical properties of crystalline solids by co-crystal formation: new compressible forms of paracetamol. Advanced Materials, 21(38–39), 3905–3909. https://doi.org/10.1002/adma.200900533
Kastelic, J., Hodnik, Ž., Šket, P., Plavec, J., Lah, N., Leban, I., Pajk, M., Planinsek, D., & Kikelj, D. (2010). Fluconazole co-crystals with dicarboxylic acids. Crystal Growth and Design, 10(11), 4943–4953. https://doi.org/10.1021/cg1010117
Kawashima, Y., Cui, F., Takeuchi, H., Niwa, T., Hino, T., & Kiuchi, K. (1994). Improvements in flowability and compressibility of pharmaceutical crystals for direct tabletting by spherical crystallization with a two-solvent system. Powder Technology, 78(2), 151–157. https://doi.org/10.1016/0032-5910(93)02772-3
Maghsoodi, M. (2012). How spherical crystallization improves direct tableting properties: A review. Advanced Pharmaceutical Bulletin, 2(2), 253–257. https://doi.org/10.5681/apb.2012.039
Pan, Y., Pang, W., Lv, J., Wang, J., Yang, C., & Guo, W. (2017). Solid state characterization of azelnidipine–oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs. Journal of Pharmaceutical and Biomedical Analysis, 138, 302–315. https://doi.org/10.1016/j.jpba.2017.02.005
Perumalla, S.R., & Sun, C. C. (2014). Enabling Tablet Product Development of 5-Fluorocytosine Through Integrated Crystal and Particle Engineering. Journal of Pharmaceutical Sciences, 103, 1126–1132. https://doi.org/10.1002/jps.23876
Ratih, Pamudji, Alatas, Soewandhi, 2018. (2018). Improving Telmisartan Mechanical Properties through the Formation of Telmisartan and Oxalic Acid Co-Crystal by using Slow Evaporation (SE) and Ultrasound Assisted Co- Crystallization from Solution (USSC) Methods. 42(1), 189–196.
Satpute, M.M., & Tour, N.S. (2013). Formulation and in vitro evaluation of fast dissolving tablets of metoprolol tartrate. 49. https://doi.org/10.1590/S1984-82502013000400018
Sun, C.C. (2011). Decoding Powder Tabletability : Roles of Particle Adhesion and Plasticity. Journal Of Adhesion Science and Technology, 25(4–5), 483–499. https://doi.org/10.1163/016942410X525678
Sun, C., & Grant, D.J.W.(2001). Influence of Crystal Structure on the Tableting Properties of Sulfamerazine Polymorphs. 18(3), 274–280. https://doi.org/10.1023/A:1011038526805
Thakuria, R., Delori, A., Jones, W., Lipert, M.P., Roy, L., & Rodriguez-Hornedo, N. (2013). Pharmaceutical co-crystals and poorly soluble drugs. International Journal of Pharmaceutics, 453, 101–125. https://doi.org/10.1016/j.ijpharm.2012.10.043
Tye, C.K., Sun, C., & Amidon, G.E. (2005). Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. Journal of Pharmaceutical Sciences, 94(3), 465–472. https://doi.org/10.1002/jps.20262
Upadhyay, P., Khomane, K.S., Kumar, L., & Bansal, A.K. (2013). Relationship between crystal structure and mechanical properties of ranitidine hydrochloride polymorphs. CrystEngComm, 15(19), 3959. https://doi.org/10.1039/c3ce40201k
Yin, X. Z., Wu, L., Li, Y., Guo, T., Li, H. Y., Xiao, T. Q., York, P., Nangia, A., Gui, S.-Y., & Zhang, J.W. (2016). Visualization and quantification of deformation behavior of clopidogrel bisulfate polymorphs during tableting. Scientific Reports, 6(November 2015), 1–11. https://doi.org/10.1038/srep21770
Zeng, G., Wang, X., Luo, S., Li, H., Tu, X., Luo, X., & Zou, J. (2014). Effect of Ultrasound on Sodium Arsenate Induction Time and Crystallization Property during Solution Crystallization Processes 1. 60(3), 356–360. https://doi.org/10.1134/S1063771014030063
